Mark Cooper
Monash university, VIC, Australia
- This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:
Anti-inflammatory Lipoxin A4 attenuates vascular dysfunction observed in diabetes-associated atherosclerosis (#255)
2:00 PM
Eoin Brennan
ADS Basic Poster Session
Contrasting Influences of Renal Function on Blood Pressure and HbA1c Reductions with Empagliflozin: Pooled Analysis of Phase III Trials (#202)
10:30 AM
Mark Cooper
ADS Clinical Orals: Kidney Function in Diabetes